Jones Trading Starts Context Therapeutics (CNTX) at Buy Dec 22, 2025 07:15AM
Context Therapeutics (CNTX) Can Swiftly Take Licensed Assets into Clinics - Citizens Nov 10, 2025 04:18AM
Context Therapeutics Inc. (CNTX) Misses Q3 EPS by 1c Nov 6, 2025 04:21PM
Context Therapeutics expands share offering program to $75 million Oct 24, 2025 04:04PM
Cantor Fitzgerald Reiterates Overweight Rating on Context Therapeutics (CNTX) Oct 2, 2025 06:03AM


Sep 17, 2025 04:11PM Guggenheim Starts Context Therapeutics (CNTX) at Buy
Jun 26, 2025 07:56AM Context Therapeutics (CNTX) PT Lowered to $4 at Piper Sandler
Jun 3, 2025 04:19AM Citizens JMP Reiterates Market Outperform Rating on Context Therapeutics (CNTX)
May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
May 29, 2025 07:31AM Context Therapeutics (CNTX) Appoint Dr. Karen Chagin as Chief Medical Officer
May 28, 2025 04:25AM Citizens JMP shares updates on cancer treatment stocks
May 7, 2025 04:17PM Context Therapeutics Inc. (CNTX) Tops Q1 EPS by 7c
May 5, 2025 04:06PM Context Therapeutics (CNTX) Announces Chief Medical Officer Transition
Apr 30, 2025 07:31AM Context Therapeutics (CNTX) Presents Preclinical and Translational Data for CT-95
Apr 21, 2025 06:37AM William Blair Starts Context Therapeutics (CNTX) at Outperform
Mar 24, 2025 05:43AM Citizens JMP Reiterates Market Outperform Rating on Context Therapeutics (CNTX)
Jan 14, 2025 04:59PM Context Therapeutics (CNTX) Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76
Jan 13, 2025 07:30AM Context Therapeutics (CNTX) Appoints Andy Pasternak as Board Chair
Jan 8, 2025 03:14AM JMP Securities Starts Context Therapeutics (CNTX) at Market Outperform
Nov 7, 2024 06:27AM Context Therapeutics Inc. (CNTX) Misses Q3 EPS by 17c
Sep 27, 2024 08:39AM Piper Sandler Reiterates Overweight Rating on Context Therapeutics (CNTX)
Sep 24, 2024 06:49AM H.C. Wainwright Reiterates Buy Rating on Context Therapeutics (CNTX)
Sep 23, 2024 07:31AM BioAtla (BCAB) and Context Therapeutics (CNTX) Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362
Sep 16, 2024 07:40AM Piper Sandler Reiterates Overweight Rating on Context Therapeutics (CNTX)
Sep 9, 2024 07:52AM Piper Sandler Reiterates Overweight Rating on Context Therapeutics (CNTX)
Sep 4, 2024 07:31AM Context Therapeutics (CNTX) Appoints Karen Smith and Luke Walker to its Board
Aug 8, 2024 06:38AM Context Therapeutics (CNTX) PT Raised to $6 at H.C. Wainwright
Aug 1, 2024 07:31AM Context Therapeutics (CNTX) Appoints Claudio Dansky Ullmann as Chief Medical Officer
Jul 11, 2024 10:30AM H.C. Wainwright Reiterates Buy Rating on Context Therapeutics (CNTX)
Jul 10, 2024 07:30AM Context Therapeutics (CNTX) Acquires Phase 1-ready T cell Engager CT-95